ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

NCI names Porter Novelli executive as director for strategic dissemination.

August 1, 2003

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010